Results 81 to 90 of about 362 (132)

Immunogenic Properties and Safety of a Quadrivalent Inactivated Subunit Adjuvanted Influenza Vaccine in Adults Aged 18 to 85 Years at the End of the COVID-19 Pandemic in the 2022-2023 Season. [PDF]

open access: yesVaccines (Basel)
Kostinov MP   +16 more
europepmc   +1 more source

Polyoxidonium® Activates Cytotoxic Lymphocyte Responses Through Dendritic Cell Maturation: Clinical Effects in Breast Cancer. [PDF]

open access: yesFront Immunol, 2019
Alexia C   +15 more
europepmc   +1 more source

Targeted Restoration of T-Cell Subsets by a Fluorinated Piperazine Derivative β-Cyclodextrin Complex in Experimental Pulmonary Inflammation. [PDF]

open access: yesMolecules
Yu V   +10 more
europepmc   +1 more source

Nanodispersions of Polyelectrolytes Based on Humic Substances: Isolation, Physico-Chemical Characterization and Evaluation of Biological Activity. [PDF]

open access: yesPharmaceutics, 2021
Uspenskaya EV   +13 more
europepmc   +1 more source

The Role of Biotics in Rosacea: A Narrative Review. [PDF]

open access: yesCureus
Avendaño-Pérez AL   +2 more
europepmc   +1 more source

Immunogenicity and Safety of the Quadrivalent Adjuvant Subunit Influenza Vaccine in Seropositive and Seronegative Healthy People and Patients with Common Variable Immunodeficiency. [PDF]

open access: yesVaccines (Basel), 2020
Kostinov MP   +8 more
europepmc   +1 more source

Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent. [PDF]

open access: yesMolecules
Zhumakova S   +11 more
europepmc   +1 more source

Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases. [PDF]

open access: yesJ Clin Med, 2021
Hocková B   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy